Table 4 Length of hospital stay, complications, side effects and arrhythmias
Variable, no (%) | Levosimendan (n = 115) | Placebo (n = 113) |
|---|---|---|
Length of hospital stay in days, mean (SD) | 13 (8) | 13 (9) |
Cardiovascular complications (within 30 days) | ||
Atrial fibrillation, n (%) | 4 (3.57%) | 6 (5.4%) |
Pulmonary embolism, n (%) | 2 (1.8%) | 4 (3.6%) |
Heart failure, n (%) | 3 (2.7%) | 3 (2.7%) |
Deep venous thrombosis, n (%) | 0 (0%) | 1 (0.9%) |
Other complications (within 30 days) | ||
Bleeding | 0 (0) | 4 (3.5) |
Sepsis | 4 (3.5) | 3 (2.7) |
Hospital Readmission | 11 (9.8) | 10 (9.0) |
Re-Surgery | 1 (0.9) | 4 (3.6) |
Side effects (within first 3 postoperative days) | ||
Pressure or tightness in the chest, (%) | 9 (7.8) | 5 (4.4) |
Pain in the chest, back, jaw, (%) | 6 (5.2) | 4 (3.5) |
Shortness of breath, (%) | 25 (22.7) | 23 (20.4) |
Sweating, (%) | 21 (18.3) | 27 (23.9) |
Nausea, (%) | 35 (30.4) | 32 (28.3) |
Vomiting, (%) | 17 (14.8) | 15 (13.3) |
Anxiety, (%) | 10 (8.7) | 9 (8.0) |
Cough, (%) | 19 (16.5) | 15 (13.3) |
Arrhythmias | ||
AV block I, (%) | 3 (2.6) | 4 (3.5) |
Bradycardia, (%) | 1 (0.9) | 3 (2.7) |
Left branch block, (%) | 0 (0) | 1 (0.8) |
Right branch block, (%) | 2 (1.7) | 0 (0) |
Tachycardia, (%) | 5 (4.3) | 3 (2.7) |
Ventricular extra systole, (%) | 10 (8.7) | 9 (8.0) |
ST-segment deviation | 5 (4.5) | 5 (4.6) |
